Looking Backwards: How Has COVID-19 Affected Oncological Patients?
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: 30 September 2024 | Viewed by 128
Special Issue Editor
Interests: cancer immunology; cell therapy; drug resistance; personalised medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Coronavirus disease (COVID-19) became a global pandemic in 2020, with a widespread impact on patients with cancer, including missed or delayed cancer diagnosis, alterations to standard treatment and risk of severe outcomes including increased morbidity or death following COVID-19.
We are pleased to invite you to contribute to this issue as we look back on the lessons learned from the COVID-19 pandemic and its impact on patients with cancer, and how we can use this to improve the outcomes for our patients.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: any COVID-19- and cancer-relevant research, especially long-term sequelae, outcomes, survival and vaccine effectiveness.
I look forward to receiving your contributions.
Dr. Alvin Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncology
- cancer
- tumours
- haematology
- COVID-19
- SARS-CoV2
- coronavirus
